Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1445

1.

Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial.

Joshi R, Galan B, Chalmers J, Perkovic V, Patel A.

Expert Rev Endocrinol Metab. 2009 Mar;4(2):111-118. doi: 10.1586/17446651.4.2.111.

PMID:
30780861
2.

The National Institute for Health Research Hyperacute Stroke Research Centres and the ENCHANTED trial: the impact of enhanced research infrastructure on trial metrics and patient outcomes.

Robinson TG, Wang X, Durham AC, Ford GA, Liao J, Littlewood S, Roffe C, White P, Chalmers J, Anderson CS; ENCHANTED Investigators.

Health Res Policy Syst. 2019 Feb 13;17(1):19. doi: 10.1186/s12961-019-0417-2.

3.

More on Causal Inference Studies.

Lederer DJ, Bell SC, Smyth AR, Chalmers JD.

Ann Am Thorac Soc. 2019 Feb 11. doi: 10.1513/AnnalsATS.201901-070LE. [Epub ahead of print] No abstract available.

PMID:
30742489
4.

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, Broderick JP, Demchuk AM, Donnan GA, Durham AC, Lavados PM, Lee TH, Levi C, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Silva F, Song L, Thang NH, Wardlaw JM, Wang JG, Wang X, Woodward M, Chalmers J, Robinson TG; ENCHANTED Investigators and Coordinators.

Lancet. 2019 Feb 6. pii: S0140-6736(19)30038-8. doi: 10.1016/S0140-6736(19)30038-8. [Epub ahead of print]

PMID:
30739745
5.

Children in Social Research: Do Higher Payments Encourage Participation in Riskier Studies?

Taplin S, Chalmers J, Hoban B, McArthur M, Moore T, Graham A.

J Empir Res Hum Res Ethics. 2019 Feb 8:1556264619826796. doi: 10.1177/1556264619826796. [Epub ahead of print]

PMID:
30735083
6.

Defining and measuring "eczema control": An international qualitative study to explore the views of those living with and treating atopic eczema.

Howells L, Thomas KS, Sears AV, Nasr I, Wollenberg A, Schuttelaar MLA, Romeijn GLE, Paller AS, Mueller K, Doytcheva K, Kataoka Y, Daguze J, Barbarot S, von Kobyletzki LB, Beckman L, Ratib S, Cowdell F, Santer M, Chalmers JR; long-term control of eczema working group for the HOME initiative.

J Eur Acad Dermatol Venereol. 2019 Feb 5. doi: 10.1111/jdv.15475. [Epub ahead of print]

PMID:
30720903
7.

Challenges in severe community-acquired pneumonia: a point-of-view review.

Torres A, Chalmers JD, Dela Cruz CS, Dominedò C, Kollef M, Martin-Loeches I, Niederman M, Wunderink RG.

Intensive Care Med. 2019 Feb;45(2):159-171. doi: 10.1007/s00134-019-05519-y. Epub 2019 Jan 31. Review.

PMID:
30706119
8.

British Thoracic Society guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn JS, Floto RA, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher WP, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR.

BMJ Open Respir Res. 2018 Dec 28;5(1):e000348. doi: 10.1136/bmjresp-2018-000348. eCollection 2018.

9.

Measuring Unmet Demand for Alcohol and Other Drug Treatment: The Application of an Australian Population-Based Planning Model.

Ritter A, Chalmers J, Gomez M.

J Stud Alcohol Drugs Suppl. 2019 Jan;Sup 18:42-50.

PMID:
30681948
10.

Key Considerations in Planning for Substance Use Treatment: Estimating Treatment Need and Demand.

Ritter A, Mellor R, Chalmers J, Sunderland M, Lancaster K.

J Stud Alcohol Drugs Suppl. 2019 Jan;Sup 18:22-30.

PMID:
30681945
11.

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.

Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE.

Lancet Respir Med. 2019 Jan 15. pii: S2213-2600(18)30427-2. doi: 10.1016/S2213-2600(18)30427-2. [Epub ahead of print] Erratum in: Lancet Respir Med. 2019 Jan 25;:.

PMID:
30658914
12.

The evolution of the European Respiratory Journal: volume 2.

Chalmers JD, Kolb M.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802459. doi: 10.1183/13993003.02459-2018. Print 2019 Jan. No abstract available.

PMID:
30655453
13.

Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.

Berkelmans GFN, Gudbjörnsdottir S, Visseren FLJ, Wild SH, Franzen S, Chalmers J, Davis BR, Poulter NR, Spijkerman AM, Woodward M, Pressel SL, Gupta AK, van der Schouw YT, Svensson AM, van der Graaf Y, Read SH, Eliasson B, Dorresteijn JAN.

Eur Heart J. 2019 Jan 9. doi: 10.1093/eurheartj/ehy839. [Epub ahead of print]

PMID:
30629157
14.

Single cell analysis of aged RBCs: quantitative analysis of the aged cells and byproducts.

Kim J, Weigand M, Palmer AF, Zborowski M, Yazer MH, Chalmers JJ.

Analyst. 2019 Jan 28;144(3):935-942. doi: 10.1039/c8an01904e.

PMID:
30617361
15.

Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.

Ohkuma T, Jun M, Rodgers A, Cooper ME, Glasziou P, Hamet P, Harrap S, Mancia G, Marre M, Neal B, Perkovic V, Poulter N, Williams B, Zoungas S, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.

PMID:
30571562
16.

British Thoracic Society Guideline for bronchiectasis in adults.

Hill AT, Sullivan AL, Chalmers JD, De Soyza A, Elborn SJ, Floto AR, Grillo L, Gruffydd-Jones K, Harvey A, Haworth CS, Hiscocks E, Hurst JR, Johnson C, Kelleher PW, Bedi P, Payne K, Saleh H, Screaton NJ, Smith M, Tunney M, Whitters D, Wilson R, Loebinger MR.

Thorax. 2019 Jan;74(Suppl 1):1-69. doi: 10.1136/thoraxjnl-2018-212463. No abstract available.

PMID:
30545985
17.

The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.

Flynn RWV, MacDonald TM, Chalmers JD, Schembri S.

Respir Res. 2018 Dec 12;19(1):249. doi: 10.1186/s12931-018-0960-3.

18.

Economic burden of bronchiectasis in Germany.

Diel R, Chalmers JD, Rabe KF, Nienhaus A, Loddenkemper R, Ringshausen FC.

Eur Respir J. 2018 Dec 5. pii: 1802033. doi: 10.1183/13993003.02033-2018. [Epub ahead of print]

PMID:
30523162
19.

New Insights Into the Epidemiology of Bronchiectasis.

Chalmers JD.

Chest. 2018 Dec;154(6):1272-1273. doi: 10.1016/j.chest.2018.08.1051. No abstract available.

PMID:
30526964
20.

ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training.

Aliberti S, Farr A, Tabin N, Blasi F, Torres A, Woodhead M, Migliori GB, Sotgiu G, Dimopoulos G, Chalmers JD, Ringshausen FC, Loebinger MR, Read R, Rohde G.

Breathe (Sheff). 2018 Dec;14(4):269-275. doi: 10.1183/20734735.026218.

21.

Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics study.

O'Neill K, Lakshmipathy GR, Ferguson K, Cosgrove D, Hill AT, Loebinger MR, Carroll M, Chalmers JD, Gatheral T, Johnson C, DeSoyza A, Hurst JR, Bradbury I, Elborn JS, Bradley JM.

Respir Med. 2018 Dec;145:206-211. doi: 10.1016/j.rmed.2018.10.030. Epub 2018 Nov 1.

PMID:
30509710
22.

A comprehensive approach to lung function in bronchiectasis.

Radovanovic D, Santus P, Blasi F, Sotgiu G, D'Arcangelo F, Simonetta E, Contarini M, Franceschi E, Goeminne PC, Chalmers JD, Aliberti S.

Respir Med. 2018 Dec;145:120-129. doi: 10.1016/j.rmed.2018.10.031. Epub 2018 Nov 2.

PMID:
30509700
23.

Bisphenol A Alters Bmal1, Per2, and Rev-Erba mRNA and Requires Bmal1 to Increase Neuropeptide Y Expression in Hypothalamic Neurons.

Loganathan N, Salehi A, Chalmers JA, Belsham DD.

Endocrinology. 2019 Jan 1;160(1):181-192. doi: 10.1210/en.2018-00881.

PMID:
30500912
24.

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

Salam A, Atkins E, Sundström J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A; Blood Pressure Lowering Treatment Trialists’ Collaboration.

J Hypertens. 2019 Jan;37(1):16-23. doi: 10.1097/HJH.0000000000001994.

PMID:
30499920
25.

Management of cellulitis: current practice and research questions.

Santer M, Lalonde A, Francis NA, Smart P, Hooper J, Teasdale E, Del Mar C, Chalmers JR, Thomas KS.

Br J Gen Pract. 2018 Dec;68(677):595-596. doi: 10.3399/bjgp18X700181. No abstract available.

PMID:
30498163
26.

The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.

Aliberti S, Polverino E, Chalmers JD, Altenburg J, Shteinberg M, Goeminne PC, Welte T, Shoemark A, Almagro M, Blasi F; EMBARC Clinical Research Collaboration.

Eur Respir J. 2018 Nov 29;52(5). pii: 1802074. doi: 10.1183/13993003.02074-2018. Print 2018 Nov. No abstract available.

PMID:
30498055
27.

Patients' understanding of cellulitis and views about how best to prevent recurrent episodes: mixed-methods study in primary and secondary care.

Teasdale EJ, Lalonde A, Muller I, Chalmers J, Smart P, Hooper J, El-Gohary M, Thomas KS, Santer M.

Br J Dermatol. 2018 Nov 19. doi: 10.1111/bjd.17445. [Epub ahead of print]

PMID:
30451281
28.

Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial.

Chalmers JD, Djamin RS, Schouten M, Keir HR, Tan B, Aerts JGJV, Huang JT, van der Eerden M.

ERJ Open Res. 2018 Nov 12;4(4). pii: 00136-2018. doi: 10.1183/23120541.00136-2018. eCollection 2018 Oct.

29.

Bronchiectasis.

Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ.

Nat Rev Dis Primers. 2018 Nov 15;4(1):45. doi: 10.1038/s41572-018-0042-3. Review.

PMID:
30442957
30.

The use of infrared thermography in the measurement and characterization of brown adipose tissue activation.

Law J, Chalmers J, Morris DE, Robinson L, Budge H, Symonds ME.

Temperature (Austin). 2018 Jan 29;5(2):147-161. doi: 10.1080/23328940.2017.1397085. eCollection 2018. Review.

31.

Palmitate Induces an Anti-Inflammatory Response in Immortalized Microglial BV-2 and IMG Cell Lines that Decreases TNFα Levels in mHypoE-46 Hypothalamic Neurons in Co-Culture.

Kim SM, McIlwraith EK, Chalmers JA, Belsham DD.

Neuroendocrinology. 2018;107(4):387-399. doi: 10.1159/000494759. Epub 2018 Oct 23.

PMID:
30352432
32.

How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis.

Terranova L, Oriano M, Teri A, Ruggiero L, Tafuro C, Marchisio P, Gramegna A, Contarini M, Franceschi E, Sottotetti S, Cariani L, Bevivino A, Chalmers JD, Aliberti S, Blasi F.

Int J Mol Sci. 2018 Oct 20;19(10). pii: E3256. doi: 10.3390/ijms19103256.

33.

Statistical analysis plan for evaluating different intensities of blood pressure control in the ENhanced Control of Hypertension And Thrombolysis strokE stuDy.

Anderson CS, Woodward M, Arima H, Chen X, Lindley RI, Wang X, Chalmers J, Robinson TG.

Int J Stroke. 2018 Oct 9:1747493018806170. doi: 10.1177/1747493018806170. [Epub ahead of print]

PMID:
30299230
34.

NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke.

Yoshimura S, Lindley RI, Carcel C, Sato S, Delcourt C, Wang X, Chalmers J, Anderson CS; ENCHANTED Investigators.

Neurology. 2018 Oct 30;91(18):e1695-e1701. doi: 10.1212/WNL.0000000000006437. Epub 2018 Sep 28.

PMID:
30266885
35.

Distinct 'Immuno-Allertypes' of Disease and High Frequencies of Sensitisation in Non-Cystic-Fibrosis Bronchiectasis.

Mac Aogáin M, Tiew PY, Lim AYH, Low TB, Tan GL, Hassan T, Ong TH, Pang SL, Lee ZY, Gwee XW, Martinus C, Sio YY, Matta SA, Ong TC, Tiong YS, Wong KN, Narayanan S, Bijin Au V, Marlier D, Keir HR, Tee A, Abisheganaden JA, Koh MS, Wang Y, Connolly JE, Chew FT, Chalmers JD, Chotirmall SH.

Am J Respir Crit Care Med. 2018 Sep 28. doi: 10.1164/rccm.201807-1355OC. [Epub ahead of print]

PMID:
30265843
36.

A systematic review of clinical trial registration in major respiratory journals 2010-2018.

Suntila NSM, Smith A, Al-Dabbagh Y, Chalmers JD.

Eur Respir J. 2018 Dec 6;52(6). pii: 1801491. doi: 10.1183/13993003.01491-2018. Print 2018 Dec. No abstract available.

PMID:
30262578
37.

Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals.

Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, Ost DE, Punjabi NM, Schatz M, Smyth AR, Stewart PW, Suissa S, Adjei AA, Akdis CA, Azoulay É, Bakker J, Ballas ZK, Bardin PG, Barreiro E, Bellomo R, Bernstein JA, Brusasco V, Buchman TG, Chokroverty S, Collop NA, Crapo JD, Fitzgerald DA, Hale L, Hart N, Herth FJ, Iwashyna TJ, Jenkins G, Kolb M, Marks GB, Mazzone P, Moorman JR, Murphy TM, Noah TL, Reynolds P, Riemann D, Russell RE, Sheikh A, Sotgiu G, Swenson ER, Szczesniak R, Szymusiak R, Teboul JL, Vincent JL.

Ann Am Thorac Soc. 2019 Jan;16(1):22-28. doi: 10.1513/AnnalsATS.201808-564PS. No abstract available. Erratum in: Ann Am Thorac Soc. 2019 Feb;16(2):283.

PMID:
30230362
38.

Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Flume PA, Chalmers JD, Olivier KN.

Lancet. 2018 Sep 8;392(10150):880-890. doi: 10.1016/S0140-6736(18)31767-7. Review.

PMID:
30215383
39.

The future of accreditation of continuing medical education (CME)-continuing professional development (CPD) in Europe: harmonisation through dialogue and consensus.

de Andrade F, Griebenow R, Costello RW, Guenova M, Schaefer R, Chalmers JD, Tichelli A, Raguz D, Stein J.

J Eur CME. 2018 Sep 3;7(1):1506202. doi: 10.1080/21614083.2018.1506202. eCollection 2018.

40.

Treatable traits in bronchiectasis.

Boaventura R, Sibila O, Agusti A, Chalmers JD.

Eur Respir J. 2018 Sep 6;52(3). pii: 1801269. doi: 10.1183/13993003.01269-2018. Print 2018 Sep. No abstract available.

PMID:
30190263
41.

Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention.

Mundra PA, Barlow CK, Nestel PJ, Barnes EH, Kirby A, Thompson P, Sullivan DR, Alshehry ZH, Mellett NA, Huynh K, Jayawardana KS, Giles C, McConville MJ, Zoungas S, Hillis GS, Chalmers J, Woodward M, Wong G, Kingwell BA, Simes J, Tonkin AM, Meikle PJ; LIPID Study Investigators.

JCI Insight. 2018 Sep 6;3(17). pii: 121326. doi: 10.1172/jci.insight.121326. [Epub ahead of print]

42.

Psychosocial Assessment Using Telehealth in Adolescents and Young Adults With Cancer: A Partially Randomized Patient Preference Pilot Study.

Chalmers JA, Sansom-Daly UM, Patterson P, McCowage G, Anazodo A.

JMIR Res Protoc. 2018 Aug 29;7(8):e168. doi: 10.2196/resprot.8886.

43.

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.

Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F; IRENE Network.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33. doi: 10.1186/s40248-018-0141-8. eCollection 2018.

44.

Get together to increase awareness in bronchiectasis: a report of the 2nd World Bronchiectasis Conference.

Aliberti S, Chalmers JD.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):28. doi: 10.1186/s40248-018-0138-3. eCollection 2018. No abstract available.

45.

Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis.

Contarini M, Shoemark A, Rademacher J, Finch S, Gramegna A, Gaffuri M, Roncoroni L, Seia M, Ringshausen FC, Welte T, Blasi F, Aliberti S, Chalmers JD.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):26. doi: 10.1186/s40248-018-0143-6. eCollection 2018. Review.

46.

Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial.

Santo K, Singleton A, Rogers K, Thiagalingam A, Chalmers J, Chow CK, Redfern J.

Heart. 2018 Aug 27. pii: heartjnl-2018-313479. doi: 10.1136/heartjnl-2018-313479. [Epub ahead of print]

PMID:
30150326
47.

Towards a better understanding of outcome measurement instruments for atopic eczema.

Chalmers JR, Danby S.

Br J Dermatol. 2018 Aug;179(2):246-247. doi: 10.1111/bjd.16827. No abstract available.

PMID:
30141558
48.

A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.

McDonnell MJ, O'Toole D, Ward C, Pearson JP, Lordan JL, De Soyza A, Loebinger M, Chalmers JD, Laffey JG, Rutherford RM.

Respir Med. 2018 Aug;141:132-143. doi: 10.1016/j.rmed.2018.06.031. Epub 2018 Jun 30. Review.

PMID:
30053958
49.

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions.

Polverino E, Dimakou K, Hurst J, Martinez-Garcia MA, Miravitlles M, Paggiaro P, Shteinberg M, Aliberti S, Chalmers JD.

Eur Respir J. 2018 Sep 15;52(3). pii: 1800328. doi: 10.1183/13993003.00328-2018. Print 2018 Sep. Review.

PMID:
30049739
50.

Bronchiectasis: a case-based approach to investigation and management.

Contarini M, Finch S, Chalmers JD.

Eur Respir Rev. 2018 Jul 11;27(149). pii: 180016. doi: 10.1183/16000617.0016-2018. Print 2018 Sep 30. Review.

Supplemental Content

Loading ...
Support Center